SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

MANSERVIGI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.183
EU - Europa 1.964
AS - Asia 1.465
SA - Sud America 8
AF - Africa 6
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.636
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.166
CN - Cina 845
UA - Ucraina 578
GB - Regno Unito 341
TR - Turchia 307
DE - Germania 281
SG - Singapore 265
IT - Italia 219
SE - Svezia 139
PL - Polonia 133
FI - Finlandia 125
BE - Belgio 36
FR - Francia 33
AT - Austria 28
CA - Canada 16
IR - Iran 14
RU - Federazione Russa 10
NL - Olanda 9
BR - Brasile 7
IN - India 7
KR - Corea 7
LT - Lituania 7
CZ - Repubblica Ceca 6
ES - Italia 5
ID - Indonesia 4
NZ - Nuova Zelanda 4
RO - Romania 4
VN - Vietnam 4
EU - Europa 3
HK - Hong Kong 3
JP - Giappone 3
MZ - Mozambico 3
AU - Australia 2
BG - Bulgaria 2
DK - Danimarca 2
LI - Liechtenstein 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
CH - Svizzera 1
EG - Egitto 1
IL - Israele 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PA - Panama 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 10.636
Salva come PNG Salva come JPEG
Città #
Woodbridge 891
Fairfield 841
Jacksonville 619
Houston 590
Chandler 504
Ann Arbor 458
Ashburn 409
Wilmington 331
Seattle 328
Cambridge 282
Santa Clara 243
Singapore 200
Nanjing 194
Beijing 193
Izmir 188
New York 142
Princeton 134
Warsaw 133
San Diego 87
Boardman 60
Shenyang 58
Shanghai 56
Milan 55
Nanchang 47
Hebei 38
Tianjin 38
Jiaxing 37
Brussels 36
Los Angeles 35
San Mateo 34
Ferrara 32
Vienna 28
Changsha 26
Jinan 23
Ningbo 23
Norwalk 20
Falls Church 19
Washington 18
Mountain View 17
Philadelphia 16
Dearborn 15
Kunming 15
Leawood 15
Auburn Hills 14
Augusta 14
Helsinki 14
London 13
Guangzhou 12
Orange 12
Munich 11
Redwood City 11
Taizhou 11
Verona 11
Zhengzhou 11
Ardabil 10
Bologna 8
Monmouth Junction 8
Toronto 8
Des Moines 7
Indiana 7
Bremen 6
Hangzhou 6
Addison 5
Brno 5
Frankfurt am Main 5
Haikou 5
Lanzhou 5
Ottawa 5
Changchun 4
Jakarta 4
Rome 4
Acton 3
Amsterdam 3
Auckland 3
Bari 3
Chicago 3
Chimoio 3
Dong Ket 3
Meda 3
Minamiyukigaya 3
Napoli 3
Novosibirsk 3
Paris 3
Pieve Emanuele 3
São Paulo 3
Taiyuan 3
Wandsworth 3
Düsseldorf 2
Genoa 2
Hong Kong 2
Hounslow 2
Las Vegas 2
Madrid 2
North Bergen 2
Pearland 2
Pune 2
Roseto Degli Abruzzi 2
Sofia 2
Tappahannock 2
Turin 2
Totale 7.838
Salva come PNG Salva come JPEG
Nome #
Novel tumour-specific promoters for transcriptional targeting of hepatocellular carcinoma by herpes simplex virus vectors 197
null 179
Antitumor effects of non-replicative herpes simplex vectors expressing antiangiogenic proteins and thymidine kinase on Lewis lung carcinoma establishment and growth. 158
Analysis of HSV isolated from patients with unilateral and bilateral herpetic keratitis 145
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 145
An Attenuated Herpes Simplex Virus Type 1 (HSV1) Encoding the HIV-1 Tat Protein Protects Mice from a Deadly Mucosal HSV1 Challenge 133
Herpetic vectors inhibiting angiogenesis and inducing cell suicide in gliomas 132
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 129
Inhibition of herpes simplex virus types 1 and 2 in vitro infection by sulfated derivatives of Escherichia coli K5 polysaccharide 129
Herpes Simplex Virus Growth, Preparation, and Assay 129
Characterization of herpes simplex virus 1 strains as platforms for the development of oncolytic viruses against liver cancer 128
Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins 127
Characterization of a herpes simplex virus type 1 mutant resistant to benzhydrazone, a selective inhibitor of herpesvirus glycosylation 124
HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy 122
An S/MAR-based infectious episomal genomic DNA expression vector provides long-term regulated functional complementation of LDLR deficiency. 121
Characterization of virus obtained from MDBK cells persistently infected with a variant of herpes simplex virus type 1 strain MP [HSV-1(MP)] 118
HSV as a vector in vaccine development and gene therapy 118
A BK virus episomal vector for constitutive high expression of exogenous cDNAs in human cells 118
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: Immunogenicity and protection in mice 118
Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model 116
Identification of replication-competent HSV-1 Cgal(+) strain targets in a mouse model of human hepatocarcinoma xenograft 116
The interferon-inducible IFI16 gene inhibits tube morphogenesis and proliferation of primary, but not HPV16 E6/E7-immortalized human endothelial cells 115
Phenotypic and genotypic characterization of locus Syn 5 in Herpes simplex virus 1. 114
A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease 114
Expression of herpes simplex virus 1 glycoprotein B in human cells and protection of mice against lethal herpes simplex virus 1 infection 114
A Lentiviral Vector-Based, Herpes Simplex Virus 1 (HSV-1) Glycoprotein B Vaccine Affords Cross-Protection against HSV-1 and HSV-2 Genital Infections 112
Replication-competent herpes simplex vectors: design and applications 112
Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1 111
Effects of the passive transfer of anti-gB antibodies in a rabbit model of HSV-1-induced keratitis 110
Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes 108
Herpesvirus/retrovirus chimeric vectors 107
null 107
Synthesis and anti-HSV-1 activity of 6 substituted pyrazolo[3,4-d]pyridazin-7-one nucleosides 106
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 106
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 106
null 104
A herpes simplex virus type 1 mutant resistant to benzhydrazone, an inhibitor of glycoprotein synthesis in herpesvirus-infected cells. Preliminary mapping of benzhydrazone-resistance and of a novel syncitial mutation 104
HSV as a vector in vaccine development and gene therapy 104
null 104
Purinergic Signaling: A New Pharmacological Target Against Viruses? 104
MEMBRANE PROTEIN PATTERN IN HEREDITARY SPHEROCYTOSIS IN FIVE SUBJECTS FROM NORTH-EAST ITALY OBTAINED BY SDS-PAGE USING N,N'-DIALLYLTARTARDIAMIDE 103
Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors 103
Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide 103
Herpesvirus-based vectors for gene transfer, gene therapy and the development of novel vaccines 102
The C-terminal cytoplasmic tail of herpes simplex virus type 1 gE protein is phosphorylated in vivo and in vitro by cellular enzymes in the absence of other viral proteins 101
Local and systemic inoculation of DNA or protein gB1s-based vaccines induce a protective immunity against rabbit ocular HSV-1 infection 100
Replication-competent herpes simplex virus type 1 mutant expressing an autofluorescent glycoprotein H fusion protein 100
null 99
Role of Herpes Simplex Envelope Glycoprotein B and Toll-Like Receptor 2 in Ocular Inflammation: An ex vivo Organotypic Rabbit Corneal Model 98
High expression of exogenous cDNAs directed by HIV-1 long terminal repeat in human cells constitutively producing HIV-1 tat and adenovirus E1A/E1B 96
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses 95
State of viral DNA in BK virus-transformed rabbit cells 95
null 95
Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread 93
HERPES-SIMPLEX VIRUS TYPE-1 (HSV-1) URACIL-DNA GLYCOSYLASE - FUNCTIONAL EXPRESSION IN ESCHERICHIA-COLI, BIOCHEMICAL-CHARACTERIZATION, AND SELECTIVE-INHIBITION BY 6-(P-N-OCTYLANILINO)URACIL 93
Cationic liposomes as carriers for ocular administration of anti herpetic peptides 92
Capitolo 55 Retrovirus 92
IMMUNIZZAZIONE PASSIVA CON SIERO POLICLONALE NELLA CHERATITE ERPETICA SPERIMENTALE 90
null 89
HSV-1 virions engineered for specific binding to cell surface receptors 88
null 88
null 88
Virus erpetici come vettori vaccinali 88
EVIDENCE FOR GLYCOPROTEIN ABNORMALITY IN PLATELETS FROM PATIENTS WITH MAY-HEGGLIN ANOMALY 87
Gene transfer into neurones for the molecular analysis of behaviour: focus on herpes simplex vectors 86
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 85
Osservazioni cliniche e microbiologiche su un campione di donne controllate ambulatoriamente 85
null 83
Temperature-sensitive mutants of HSV-1: Complementation and partial characterization 83
null 81
null 80
Molecular diagnosis of herpes simplex encephalitis 78
Intra-tissue characteristics of chloroplasts in the lamina and petiole of mature winter leaf of Arum italicum Miller 77
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 76
Protective immunity against genital herpes in mice obtained by non-ionic surfactant vesiclescontaining a secreted recombinant form of gB protein 74
CELL-TYPE DEPENDENT SENSITIVITY OF HERPES-SIMPLEX-VIRUS-1 MUTANTS TO PLAQUE DEVELOPMENT INHIBITION BY AN ANTI-GD MONOCLONAL-ANTIBODY 74
HERPES-SIMPLEX VIRUS TYPE-1 URACIL-DNA GLYCOSYLASE - CLONING AND CHARACTERIZATION 73
Eudragit microparticles as a possible tool for ophthalmic administration of acyclovir 72
In vitro antiviral activity of Emblica officinalis extracts and GC/MS identified compounds 69
Expression of the herpes simplex virus type 1 glycoprotein E in human cells and in Escherichia coli: Protection studies against lethal viral infection in mice 68
Poster: Herpes simplex vaccine vector co-expressing fused Mycobacterium Tuberculosis immunogens and Tat adjuvant enhances cellular and humoral responses in Balb/c mice 67
Niosomes containing HSV immunogens as possible vaccine against genital herpes 66
Constitutive expression in human cells of herpes simplex type 1 glycoprotein B gene cloned in an episomal eukaryotic vector 65
Inhibition of human immunodeficiency virus reactivation from latency by a tat transdominant negative mutant 65
Effetto sterilizzante dell'acido peracetico su siero da impiegarsi per la coltivazione in vitro delle cellule animali. 65
Espressione in cellule umane del gene della glicoproteina B del virus dell'herpes simplex inserito in un vettore eucariotico 64
Transformation by defined regions of herpes simplex virus DNA. 64
Capitolo 44 Herpesviridae 64
Intranasal immunization with non-ionic surfactant vescicles containing a secreted recombinant form of gB protein confers protective immunity against genital herpes in mice 61
The expression of immediate early genes of herpes simplex virus type 1 contributes to the neuroplasticity induced by viral infection on the enteric nervous system 61
Ocular disease patterns caused by genetically related mutants of Herpes simplex virus type 1. 61
Plaque dissociation of herpes sinplex viruses: biochemical and biological characters of the viral variants 60
Niosomes for vaginal administration of an antiherpetic peptide 60
HIV-1 matrix protein p17 modulates in vivo preactivated murine T-cell response and enhances the induction of systemic and mucosal immunity against intranasally co-administered antigens 59
Comunicazione orale, KN: A New Vaccine Approach To Fight Mycobacterium Tuberculosis 59
Gene therapy of the nervous system by herpes virus vectors 59
Immunotherapeutic activity of a recombinant glycoprotein vaccine aganst recurrent genital herpes in a guinea pig model. 58
Molecular analysis of behavior by gene transfer into neurons with herpes simplex vectors 57
Sequences homologous to two separate transforming regions of herpes simplex virus DNA are linked in two genital tumors 57
Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays 57
Totale 9.615
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.605
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.981
Totale 49.586
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.400 0 0 0 0 142 232 180 244 148 238 176 40
2020/20211.461 136 124 69 152 66 173 65 175 24 175 227 75
2021/20221.407 58 137 86 83 76 48 70 65 56 91 124 513
2022/20231.152 131 48 64 149 176 186 42 106 143 10 68 29
2023/2024672 68 78 29 24 60 180 38 39 15 7 7 127
2024/2025651 59 48 186 88 270 0 0 0 0 0 0 0
Totale 10.730